Immunogenicity and safety of Cervarix HPV-16/18 AS04-adjuvant vaccine against HPV induced cervical cancer in women (15+ years). Student Medical Journal [Internet]. 2024 Oct. 10 [cited 2024 Nov. 21];3:50-61. Available from: https://journals.ucc.ie/index.php/smj/article/view/4323